In vivo tracking of tumor-specific T cells (Q34167930)

31 July 2017

title

In vivo tracking of tumor-specific T cells (English)

1 reference

31 July 2017

Yee C

1

1 reference

31 July 2017

Riddell SR

series ordinal

2

1 reference

31 July 2017

Greenberg PD

series ordinal

3

1 reference

31 July 2017

publication date

1 April 2001

1 reference

Current Opinion in Immunology

31 July 2017

published in

1 reference

31 July 2017

volume

13

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

141-146

1 reference

publication type of scholarly work

31 July 2017

review article

1 reference

T cell defined tumor antigens

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Flow cytometric measurement of intracellular cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Direct visualization of antigen-specific T cells: HTLV-1 Tax11–19- specific CD8+T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

CD8(+) T-cell selection, function, and death in the primary immune response in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

In situ detection of virus- and tumor-specific T-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Massive Expansion of Antigen-Specific CD8+ T Cells during an Acute Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

A New Look at T Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Antigen-independent activation of naive and memory resting T cells by a cytokine combination

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Status of activation of circulating vaccine-elicited CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

10.1016/S0952-7915(00)00196-5

Identifiers

DOI

1 reference

31 July 2017

1 reference